MedTrace Logo

Selective Block of the Axillary Nerve in Postoperative Pain Management

NCT01463865 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-03-20

No results posted yet for this study

Summary

In this study the investigators wish to compare the effect of a selective axillary nerve block to placebo in patients undergoing arthroscopic shoulder surgery.

It is the investigators hypothesis that the amount of morphine consumption in the first 4 hours postoperatively in the intervention group will be significant lower than in the placebo group.

Conditions

  • Pain, Postoperative

Interventions

DRUG

ropivacaine

Single shot nerve block with ropivacaine 10-20 ml; 7,5 mg/ml

DRUG

Sodium chloride

Single shot nerve block with isotonic sodiumchloride 10-20 ml; 0.9%

Sponsors & Collaborators

  • Hillerod Hospital, Denmark

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01463865 on ClinicalTrials.gov